Insmed News and Activities
Presence
Insmed is a pharmaceutical company that develops and sells therapies for serious rare diseases. Its products and research services focus on lung and inflammatory conditions for patients, healthcare providers, and specialty care centers.
Insmed products and services overview:
- Rare disease drugs
- Lung disease therapies
- Inflammation treatments
- Biologic medicines
- Clinical research
Revenue: ~$364 million
Employees: 1,200
Headquarters: Bridgewater, United States (USA)
Insmed is one of the...
Insmed is a company listed under the stock ticker INSM (US).
Executives
View the org chart displaying its 35 main executives
Most searched biographies at Insmed
- Will Lewis, President, Chief Executive Officer and Chairman of the...
- Melvin Sharoky, Director
- Leo Lee, Director
Popular executive movements at Insmed
- Samuele Butera has joined the company as Senior Vice President, General Manager, Global Respiratory (posted on June 23 2026).
Create your alert
to follow the executive moves at Insmed.
Pharmaceuticals
Insmed has 1,913 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Popular M&A news in Pharmaceuticals
- Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).
- Polpharma has acquired Biofarm (posted on June 24 2026).
- AbbVie has announced the acquisition of Apogee Therapeutics (posted on June 23 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Insmed
- News Releases - Insmed
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Insmed Incorporated
- Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities for 2019 | Insmed Incorporated
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Insmed Incorporated
- Insmed Announces Changes to its Board of Directors | Insmed Incorporated
- Insmed to Present at Three November Conferences | Insmed Incorporated
- Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update | Insmed Incorporated
- Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018 | Insmed Incorporated
- Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatment with ARIKAYCE® (amikacin liposome inhalation suspension) | Insmed Incorporated
- Insmed Extends Patent Protection in Japan to 2033 | Insmed Incorporated
- View more press releases Close
Social media about Insmed
- Insmed on Wikipedia, Google News & Yahoo Finance
- Insmed on LinkedIn, X (Twitter) & YouTube
